Best TRT Injection for 2026: Fridays Lists Prescription Testosterone in Injectable and Oral Formats as Men Compare Telehealth Hormone Options Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research indicates for men evaluating prescription testosterone pathways heading into 2026. GlobeNewswire December 27, 2025 IRVINE, Dec. 27, 2025 (GLOBE NEWSWIRE) […]

iTagPro Bluetooth Tracker: How the iTag Pro Technology Works, What It Can and Cannot Do, and Who It May Be Right For in 2026 Independent Analysis Examines iTagPro's Bluetooth Technology, Realistic Use Cases, Limitations, and How to Determine If It Matches Your Tracking Needs GlobeNewswire December 27, 2025 NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE)

(NasdaqGM:NUAI), NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of New Era Energy & Digital, Inc. (NASDAQ: NUAI) resulting from allegations that New Era Energy & Digital may have issued materially misleading business information

NUAI Announcement: If You Have Suffered Losses in New Era Energy & Digital, Inc. (NASDAQ: NUAI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire December 27, 2025 NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential

(NASDAQ:FFIV), NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of F5, Inc. (NASDAQ: FFIV) between October 28, 2024 and October 27, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FFIV GlobeNewswire December 27, 2025 NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of

(NASDAQ:TLX), NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”), of the important January 9, 2026 lead plaintiff deadline in the securities

TLX DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Telix Pharmaceuticals Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX GlobeNewswire December 27, 2025 NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a

NEW YORK CITY, NY / ACCESS Newswire / December 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

— SKT consortium conducts Korean government's 'Sovereign AI Foundation Model' project with A.X K1, positioning Korea for Global Top 3 AI Powers — A.X K1: Korea's first 'Teacher Model' for smaller and specialized applications — SK Telecom realizes AI as public good, advancing Korean government's 'AI for Everyone' with 20 million-user service foundation — SKT